Anand Kiran Parikh, President and CEO at Faeth Therapeutics, Inc. (FTH), bought 56,271 shares at $19.76 ($117K) on 2026-06-22, disclosed to the SEC on 2026-06-24.
CEO Anand Kiran Parikh purchased 2,806 shares for $55,447 at $19.76, a move that is flagged as the largest insider purchase in the company's history. This significant buy from the top executive suggests strong conviction in the company's near-term prospects amidst recent stock appreciation.
The stock has surged 54.3% over the last five days and 45.82% over the past month, currently trading at $26.00. The shares are trading 138.42% above their 52-week low of $10.91 but remain 19.25% below the 52-week high of $32.20.
Insider momentum: The trade is flagged as the largest insider purchase ever recorded for the company. Sector comparison: The stock has outperformed the industry, which saw a 9.27% net buyer flow over the last 90 days.
Valuation: The stock is trading at a forward P/E of -6.52, indicating negative earnings expectations. Short interest: The float has a short interest percentage of 3.21%.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.16 | 8,213 | $10K | 8.1% |
| 2 | $1.16 | 45,252 | $52K | 44.7% |
| 3 | $19.76 | 2,806 | $55K | 47.2% |
| Total | $2.09 avg | 56,271 | $117K | 100% |